Literature DB >> 11782923

Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997.

J E van Steenbergen1, H G M Niesters, E L M Op de Coul, G J J van Doornum, A D M E Osterhaus, A Leentvaar-Kuijpers, R A Coutinho, J A R van den Hoek.   

Abstract

To gain insight into the spread of hepatitis B among various risk groups in Amsterdam a 6-year (1992-1997) retrospective DNA sequencing study was carried out on isolates from stored sera from reported primary cases of acute hepatitis B infection. Cases were classified according to risk behavior, as determined in interviews. Of the available serum, a selected region of hepatitis B-virus-DNA was amplified and sequenced. The nucleotide alignments were subjected to phylogenetic tree analysis. When nucleotide alignments were subjected to phylogenetic analysis, the strains of 54 isolates, 26% of the 204 reported primary cases, clustered in five genotypes: A, C, D, E, and F. In genotype A, a cluster related to men having sex with men was identified. In genotype D, two subclusters could be identified: one was related to injecting drug use and another was related to the Moroccan population in Amsterdam. The remaining strains showed a high genetic variability within three different genotypes: F, E, and C. Of the 14 identical isolates in the "homosexual men cluster," one was isolated from a female heterosexual. Of the 14 identical strains in the "drug users strain," six were from non-drug using heterosexual active individuals. In the cluster of twelve isolates related to hepatitis B-endemic areas, probable modes of transmission were varied. Sequence analysis provides important insight into the spread of hepatitis B among various high-risk groups. The analysis indicates that the prevention strategy in The Netherlands fails to stop transmission of hepatitis B from persistently infected individuals originating from hepatitis B endemic countries. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782923     DOI: 10.1002/jmv.2125

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Origin and evolutionary dynamics of Hepatitis B virus (HBV) genotype E in Madagascar.

Authors:  Alessandra Lo Presti; Soa Fy Andriamandimby; Alessia Lai; Silvia Angeletti; Eleonora Cella; Giovanni Mottini; Michele Pier Luca Guarino; Claudia Balotta; Massimo Galli; Jean-Michel Heraud; Gianguglielmo Zehender; Massimo Ciccozzi
Journal:  Pathog Glob Health       Date:  2017-01-12       Impact factor: 2.894

2.  Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.

Authors:  G Rosner; Y Lurie; L Blendis; Z Halpern; R Oren
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

Review 3.  Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter?

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Chiara Sorrentino; Alessandra Lo Presti; Elisabetta Tanzi; Massimo Ciccozzi; Massimo Galli
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

4.  HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article.

Authors:  R Ranjbar; A Davari; M Izadi; N Jonaidi; S M Alavian
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

5.  Differences in avoidable mortality between migrants and the native Dutch in The Netherlands.

Authors:  I Stirbu; A E Kunst; V Bos; J P Mackenbach
Journal:  BMC Public Health       Date:  2006-03-27       Impact factor: 3.295

6.  Global and regional dispersal patterns of hepatitis B virus genotype E from and in Africa: A full-genome molecular analysis.

Authors:  Luicer Anne Olubayo Ingasia; Evangelia Georgia Kostaki; Dimitrios Paraskevis; Anna Kramvis
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

Review 7.  Genotype E: The neglected genotype of hepatitis B virus.

Authors:  Luicer Anne Olubayo Ingasia; Constance Wose Kinge; Anna Kramvis
Journal:  World J Hepatol       Date:  2021-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.